Neurotech International Archives | Cannabiz

Neurotech opens US pathway for NTI164 after FDA clearance

by Adam Sheldon July 14, 2026July 15, 2026

Neurotech International has received Investigational New Drug (IND) clearance from the US Food and Drug Administration […]

Financial news in brief: Avecho CBD trial latest; Argent’s milestone delivery; Neurotech reassures ASX

by Steve Jones April 29, 2026June 8, 2026

Autism data hits ‘registration benchmark’ as Neurotech prepares for Phase III clinical trial

by Adam Sheldon March 25, 2026March 26, 2026

News in brief: Vitura signs MedReleaf deal; Neurotech initiates first site for Phase 3 autism trial

by Adam Sheldon March 17, 2026June 8, 2026

News in brief: Epsilon launches biotech arm; LGP sells WA facility for $7.8m; Neurotech partners with University of Sydney on Rett program

by Adam Sheldon February 18, 2026June 8, 2026

Financial news in brief: Avecho; InhaleRx; Neurotech; Peak; Zelira; Argent

by Adam Sheldon February 2, 2026June 8, 2026

News in brief: ASX questions Neurotech over funding; participants sought for endometriosis trial in Sydney

by Adam Sheldon October 29, 2025February 21, 2026

Cannabis executive salaries: who earned what in FY25

by Adam Sheldon October 22, 2025October 22, 2025

Financial news in brief: Elixinol reassures ASX over financing; NTI shuts down two subsidiaries

by Steve Jones August 1, 2025August 1, 2025

Dr Bonni Goldstein joins Neurotech push to register cannabis drug for paediatric patients

by Steve Jones June 16, 2025June 16, 2025